Korean J Gastrointest Endosc.  2006 Apr;32(4):260-265.

The Relationship between Endoscopic Degrees and Prognostic Factors in Pseudomebranous Colitis

Affiliations
  • 1Department of Internal Medicine, Institute of Gastroenterology, Soon Chun Hyang University College of Medicine, Cheonan Hospital, Cheonan, Korea. euschung@schch.co.kr

Abstract

BACKGROUND/AIMS: Leukocytosis and hypoalbuminemia are known to be poor prognostic factors. The aim of this study was to determine how the leukocyte counts and albumin level are related to the colonic endoscopic findings.
METHODS
Fifty three pseudomembranous colitis (PMC) patients confirmed by a lower endoscopy were analyzed. Endoscopic degree of pseudomembranous plaque was classified into four grades. The endoscopic severity was classified into two groups (group A: G I~II, group B: G III~IV).
RESULTS
The mean age was 64.9 years, the mean onset of diarrhea after exposure to antibiotics was 12.9 days, the reasons for admission were medical (58.5%, 31) and surgical (41.5%, 22). Frequently the causative antibiotic was cephalosporin (81.1%, 43/53), and the mean WBC counts and albumin level were 13,045/mm3 and 3.13 g/dL, respectively. The endoscopic degrees of PMC was grade I (9.4%, 5), grade II (32.1%, 17), grade III (41.5%, 22), and grade IV (17%, 9). The patients' WBC counts and albumin level were not associated with the endoscopic severity. The age, gender, causative antibiotics, diabetes showed no correlation.
CONCLUSIONS
There were no correlations between the known poor clinical prognostic factors (leukocystosis and hypoalbuminemia) and the endoscopic severity.

Keyword

Pseudomembranous colitis; Endoscopic severity

MeSH Terms

Anti-Bacterial Agents
Colitis*
Colon
Diarrhea
Endoscopy
Enterocolitis, Pseudomembranous
Humans
Hypoalbuminemia
Leukocyte Count
Leukocytosis
Anti-Bacterial Agents
Full Text Links
  • KJGE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr